Related references
Note: Only part of the references are listed.Current limitations and future opportunities for epigenetic therapies
F. Cherblanc et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines
Masanari Takahashi et al.
JOURNAL OF ANTIBIOTICS (2012)
On the Determination of the Stereochemistry of Semisynthetic Natural Product Analogues using Chiroptical Spectroscopy: Desulfurization of Epidithiodioxopiperazine Fungal Metabolites
Fanny Cherblanc et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Epipolythiodiketopiperazine Alkaloids: Total Syntheses and Biological Activities
Eriko Iwasa et al.
ISRAEL JOURNAL OF CHEMISTRY (2011)
Total Synthesis of (+)-Chaetocin and its Analogues: Their Histone Methyltransferase G9a Inhibitory Activity
Eriko Iwasa et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase
Jennifer D. Tibodeau et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1α (HIF-1α) and p300 by a Zinc Ejection Mechanism
Kristina M. Cook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protein methyltransferases as a target class for drug discovery
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
Share Paper
